The creator notes Eden recently partnered with her employer but says the review itself isn't sponsored. Few details beyond that.
Recap by typeshit. Video by @lawliepop on TikTok.
The MFDS approval rests on SURPASS-CVOT, where Mounjaro matched Trulicity on heart events in 13,000+ patients but did not prove superior.
Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
Widmer covers the sterility concerns behind the recall of some compounded GLP-1 injections and what patients with affected medication should do.
Tirzepatide is the first dual GIP and GLP-1 drug cleared to cut major cardiovascular events, backed by the head-to-head SURPASS-CVOT trial.
Loading…